Sign in Subscribe
Diseases

New Research Reveals Triglyceride/HDL Ratio as Effective Marker for Non-Alcoholic Fatty Liver Disease

Strategic Insights

— 1 min read

Researchers at the University of Health Sciences in Istanbul, Turkey, have made a significant discovery in the field of non-alcoholic fatty liver disease (NAFLD). A study examining the triglyceride (TG)-to-high-density-lipoprotein (HDL) ratio as a potential biomarker for early detection of NAFLD has yielded promising results. The research involved 2,588 patients who met the inclusion criteria and utilized electronic health records, abdominal ultrasonography, and non-invasive scores to assess fatty liver.

Key Takeaways:

  • The TG/HDL ratio was significantly higher in NAFLD patients, with an area under the receiver operating characteristic curve (AUROC) of 0.682.
  • The TG/HDL ratio outperformed other non-invasive indices, including APRI, FIB-4, ALT/AST, and TG/glucose.
  • At the optimal cut-off value of 1.86, the sensitivity was 80.7% and the specificity was 45.5%.
  • The TG/HDL ratio correlated positively with markers of glycemic control, inflammation, and liver enzymes.
  • The research concluded that the TG/HDL ratio is an accessible and valuable parameter for predicting non-alcoholic fatty liver disease.
  • The study's findings suggest that the TG/HDL ratio offers a non-invasive alternative to liver biopsy and potentially prevents complications from non-alcoholic fatty liver disease or diagnostic approaches.

Statistics:

  • 2,588 patients were included in the study, making it one of the largest retrospective cross-sectional studies on NAFLD.
  • The TG/HDL ratio was significantly higher in NAFLD patients, with an AUROC of 0.682.
  • The sensitivity and specificity of the TG/HDL ratio at the optimal cut-off value of 1.86 were 80.7% and 45.5%, respectively.

Sources:

  • "The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients" (Diagnostics, 2025, 15(16):2045)
  • Diagnostics - http://www.mdpi.com/journal/diagnostics
  • MDPI AG - the publisher of Diagnostics
  • University of Health Sciences, Istanbul, Turkey - the research institution behind the study
  • NewsRx, "New Findings from University of Health Sciences Describe Advances in Non-Alcoholic Fatty Liver Disease (The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients)" (Health & Medicine Week, September 12, 2025; p 3425)

Read more